BioSpace News Archive

BioMed X announced today the start of a new joint research group in collaboration with Boehringer Ingelheim at the BioMed X Innovation Center in Heidelberg

Mesoblast Limited reported that the United States Food and Drug Administration has agreed to the selection of Ryoncil™ as the commercial name for its lead allogeneic cell therapy remestemcel-L in the treatment of pediatric steroid-refractory acute graft versus host disease.

Athersys, Inc. announced the addition of Mr. Ivor Macleod, CPA, MBA, a highly experienced pharmaceutical executive, to the Athersys leadership team.

ChromaDex receives authorizations to sell its patented, NAD+ boosting nicotinamide riboside chloride in the European Union and in Australia with market exclusivity

Stratus™ Medical is a new company created to focus on advancing radiofrequency ablation treatment for chronic pain.

Eli Lilly and Company (NYSE: LLY), together with leaders of the MBC community, conducted a national survey to better understand the unique challenges people living with MBC face daily.

Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, today announced receipt of an Administrative Acceptance Review Notification for the Company’s Premarket Approval application (“PMA”) from the U.S. Food and Drug Administration (“FDA”) for its Neovasc Reducer

The management team of Specialty diagnostics company Precipio, Inc., would like to provide several clarification points related to the recent S-1 that was filed yesterday, on January 14, 2020

IDEXX Laboratories, Inc. announced organizational changes to its global Companion Animal Group business aligned with leveraging best practices and execution capabilities to support global market development and sustained double-digit revenue growth.

Like famous scientists before him, Vincent Hayward, co-founder of Actronika, a start-up specializing in haptics, has been invited to join the prestigious Academy of Sciences.